Brief: Nkarta Presents Nkx019 Clinical Data At The European Hematology Association 2023 Congress And 17Th International Conference On Malignant Lymphoma
10/06/2023 15:51
June 10 (Reuters) - Nkarta Inc NKTX.O :
* NKARTA PRESENTS NKX019 CLINICAL DATA AT THE EUROPEAN
HEMATOLOGY
ASSOCIATION 2023 CONGRESS AND 17TH INTERNATIONAL CONFERENCE ON
MALIGNANT LYMPHOMA
* NKARTA - 7 OF 10 R/R NHL PATIENTS ACHIEVED COMPLETE
RESPONSE
FOLLOWING TREATMENT WITH NKX019 MONOTHERAPY
Source text for Eikon: ID:nGNXF9qNY
Further company coverage: NKTX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Nkarta
See all newsNkarta, Inc. reports results for the quarter ended June 30 - Earnings Summary
Biotech firm Nkarta posts Q2 net loss; cash runway into 2029
Brief: Nkarta Q2 EPS USD -0.54
Nkarta, Inc. expected to post a loss of 38 cents a share - Earnings Preview
Biotech experts want FDA drug reviews based on science, not politics (updated)